首页> 外文期刊>The lancet oncology >KRAS 3'-UTR variants and stratification of breast-cancer risk.
【24h】

KRAS 3'-UTR variants and stratification of breast-cancer risk.

机译:KRAS 3'-UTR变异与乳腺癌风险分层。

获取原文
获取原文并翻译 | 示例
           

摘要

In the past 15 years, a novel form of gene regulation has been discovered that is driven by the interaction of short, non-coding RNAs known as microRNAs (miRNAs) with target mRNA transcripts. On the basis of imperfect basepairing with the 3'-untranslated regions (UTRs) of target mRNAs, miRNAs negatively regulate both protein translation and mRNA stability. One of the first miRNAs to be discovered was let-7- First described as a regulator of developmental timing in the nematode, several studies in the past few years have suggested a role for the let-7 miRNA family in tumorigenesis.1"3 Expression of mature let-7-family miRNAs is suppressed in various cancer types. Moreover, this suppression frequently occurs via overactivation of the L/N28 oncogene, which specifically blocks the processing of let-7 into a functional miRNA.
机译:在过去的15年中,人们发现了一种新型的基因调控形式,这种调控形式是由称为microRNA(miRNA)的短非编码RNA与目标mRNA转录物的相互作用所驱动。基于与靶标mRNA的3'-非翻译区(UTR)的不完全碱基配对,miRNA负调控蛋白质翻译和mRNA稳定性。首先发现的miRNA之一是let-7-首先被描述为线虫发育时间的调节剂,过去几年中的一些研究表明let-7 miRNA家族在肿瘤发生中具有重要作用。1“ 3表达在多种癌症类型中,成熟的let-7家族miRNA的表达受到抑制,而且这种抑制通常通过L / N28癌基因的过度激活而发生,这特别阻止了let-7加工为功能性miRNA。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号